Observed situation in France for the week 50 of the year 2024, from 12/09/2024 to 12/15/2024 :
Published on 12-18-2024 18:12 - These news are updated on wednesday
Acute Respiratory Infection (ARI) Covid-19, Influenza and other respiratory viruses Définition
Moderate activity in general practice
Previously on sentiweb
In mainland France, last week (2024w50), the incidence rate of acute respiratory infection (ARI) cases seen in general practice consultation was estimated at 348 cases per 100,000 population (95% CI [339; 358]) (data sources: Sentinelles and IQVIA (EMR)).
Subject to future data consolidation, this rate continues the increase observed since the beginning of November (2024w45) (consolidated data for 2024w49: 273 [265; 281]).
At the regional level, the highest incidence rates were noted in: Normandie (557 [505; 610]), Provence-Alpes-Côte d’Azur (452 [413; 491]) and Grand Est (449 [410; 488]).
RSV infection: the incidence rate of RSV infection cases seen in general practice among patients consulting for an ARI was estimated at 37 cases per 100,000 population (95% CI [27; 46]) (data sources: Sentinelles, SOS Médecins, Rouen and Côte d’Azur Universities).
Subject to future data consolidation, this rate is slightly decreasing compared to the previous week (consolidated data for 2024w49: 46 [37; 56]) but remains at a moderate level of activity.
Bronchiolitis in children under 2: the incidence rate of bronchiolitis cases in children under 2 seen in general practice was estimated at 472 cases per 100,000 population (95% CI [384; 560]) (data source: IQVIA (EMR)).
Subject to future data consolidation, this rate is stable compared to the previous week (data consolidated for 2024w49: 485 [397; 573]).
Influenza: the incidence rate of influenza cases seen in general practice among patients consulting for an ARI was estimated at 83 influenza cases per 100,000 population (95% CI [67; 100]) (data sources: Sentinelles, SOS Médecins, DUMG Rouen and DERMG Côte d’Azur).
Subject to future data consolidation, this rate is moderately increasing compared to the previous week (consolidated data for 2024w49: 70 [58; 82]).
Covid-19: the incidence rate of Covid-19 cases seen in general practice among patients consulting for an ARI was estimated at 19 cases per 100,000 population (95% CI [15; 23]) (data source: Sentinelles).
Subject to future data consolidation, this rate is stable compared to the previous week (consolidated data for 2024w49: 19 [16; 23]).
Estimated weekly incidence rate | Estimated weekly incidence | |
---|---|---|
France | 348 [339 ; 358] | 232320 [226192 ; 238448] |
Regions | ||
Grand Est | 449 [410 ; 488] | 25440 [23249 ; 27631] |
Nouvelle-Aquitaine | 303 [271 ; 336] | 18822 [16813 ; 20831] |
Auvergne-Rhône-Alpes | 277 [251 ; 303] | 22951 [20801 ; 25101] |
Bourgogne-Franche-Comté | 173 [140 ; 206] | 4964 [4010 ; 5918] |
Bretagne | 426 [374 ; 478] | 14847 [13041 ; 16653] |
Centre-Val de Loire | 285 [246 ; 324] | 7499 [6471 ; 8527] |
Corse | 174 [92 ; 256] | 614 [325 ; 903] |
Ile-de-France | 343 [326 ; 359] | 42584 [40576 ; 44592] |
Occitanie | 271 [238 ; 304] | 16646 [14598 ; 18694] |
Hauts-de-France | 317 [286 ; 347] | 19270 [17401 ; 21139] |
Normandie | 557 [505 ; 610] | 18944 [17146 ; 20742] |
Pays de la Loire | 284 [234 ; 334] | 11204 [9224 ; 13184] |
Provence-Alpes-Côte d'Azur | 452 [413 ; 491] | 23517 [21490 ; 25544] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
Acute diarrhea Définition
Low activity in general practice
Previously on sentiweb
In mainland France, last week (2024w50), the incidence rate of acute diarrhea cases seen in general practice was estimated at 72 cases per 100,000 population (95% CI [68; 76]).
Subject to future data consolidation, this rate is slightly increasing since early November (2024w45) (consolidated data for 2024w49: 69 [65; 73]), but remains at a lower level of activity than those usually observed during this period.
At the regional level, the highest incidence rates were noted in: Grand Est (112 [93; 131]), Hauts-de-France (93 [76; 109]) and Bretagne (71 [50; 92]).
Data sources: Sentinelles and IQVIA (EMR)
Estimated weekly incidence rate | Estimated weekly incidence | |
---|---|---|
France | 72 [68 ; 76] | 47860 [45062 ; 50658] |
Regions | ||
Grand Est | 112 [93 ; 131] | 6344 [5252 ; 7436] |
Nouvelle-Aquitaine | 64 [50 ; 79] | 3980 [3075 ; 4885] |
Auvergne-Rhône-Alpes | 64 [53 ; 76] | 5336 [4401 ; 6271] |
Bourgogne-Franche-Comté | 54 [34 ; 74] | 1551 [974 ; 2128] |
Bretagne | 71 [50 ; 92] | 2471 [1733 ; 3209] |
Centre-Val de Loire | 69 [50 ; 88] | 1806 [1303 ; 2309] |
Corse | 68 [18 ; 117] | 238 [63 ; 413] |
Ile-de-France | 64 [57 ; 71] | 8010 [7134 ; 8886] |
Occitanie | 62 [46 ; 77] | 3785 [2853 ; 4717] |
Hauts-de-France | 93 [76 ; 109] | 5642 [4624 ; 6660] |
Normandie | 50 [33 ; 67] | 1700 [1135 ; 2265] |
Pays de la Loire | 60 [37 ; 83] | 2358 [1459 ; 3257] |
Provence-Alpes-Côte d'Azur | 62 [47 ; 76] | 3213 [2464 ; 3962] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
In mainland France, last week (2024w50), the incidence rate of Chickenpox cases seen in general practice was estimated at 8 cases per 100,000 population (95% CI [7; 10]).
Subject to future data consolidation, this rate is slightly increasing since two weeks(consolidated data for 2024w49: 7 [6; 9]) but remains at a lower level of activity than those usually observed during this period.
(*) In order to compare trends observed between pre-COVID-19 and post-COVID-19 periods, data collected between week 01 of 2016 (2016w01) and up to 2020w11 (start date of the pandemic) are shown in the grey area (pre-COVID-19 seasons). The 2019-2020 season (from week 2020w12) and subsequent seasons are represented by distinct curves in blue (post-COVID-19 seasons). The current season is shown in red.
Estimated weekly incidence rate | Estimated weekly incidence | |
---|---|---|
France | 8 [7 ; 10] | 5559 [4614 ; 6504] |
Regions | ||
Grand Est | 4 [0 ; 8] | 232 [11 ; 453] |
Nouvelle-Aquitaine | 5 [1 ; 9] | 305 [55 ; 555] |
Auvergne-Rhône-Alpes | 6 [3 ; 10] | 520 [219 ; 821] |
Bourgogne-Franche-Comté | 9 [2 ; 16] | 252 [45 ; 459] |
Bretagne | 3 [0 ; 6] | 99 [0 ; 222] |
Centre-Val de Loire | 8 [1 ; 15] | 207 [20 ; 394] |
Corse | 21 [0 ; 45] | 74 [0 ; 158] |
Ile-de-France | 9 [7 ; 12] | 1140 [811 ; 1469] |
Occitanie | 15 [6 ; 23] | 896 [381 ; 1411] |
Hauts-de-France | 10 [5 ; 16] | 630 [276 ; 984] |
Normandie | 8 [1 ; 14] | 260 [37 ; 483] |
Pays de la Loire | 8 [1 ; 15] | 314 [45 ; 583] |
Provence-Alpes-Côte d'Azur | 12 [6 ; 17] | 601 [297 ; 905] |
Table showing incidence and incidence rate for the geographic area of the information bloc and eventually for the geographic sub-levels
Warning
COVID-19 and Influenza Surveillance : role of the Sentinelles network
In March 2020, following the emergence of SARS-CoV-2 (COVID-19), the “Sentinelles surveillance” evolved. The surveillance of “influenza-like illness” (ILI, defined as sudden onset of fever above 39°C, accompanied by myalgia and respiratory signs) has been replaced by “acute respiratory infections” (ARI, defined as sudden onset of fever or feeling of fever and respiratory signs). This new surveillance enables both the monitoring of the COVID-19 pandemic and epidemics due to other respiratory viruses (influenza, respiratory syncytial virus, rhinovirus and metapneumovirus), based on patients consulting a general practitioner for an ARI. This surveillance is carried out with “Santé publique France” (the national agency for public health), the National Reference Center for respiratory infections (“Institut Pasteur” and “Hospices Civils de Lyon”) and the University of Corsica.
Data from the Sentinelles network are integrated into the overall national COVID-19 surveillance coordinated by “Santé publique France”. For more information, you can consult the weekly COVID-19 and influenza newsletters from “Santé publique France”.
At the same time, the Sentinelles network is leading studies and research works on the COVID-19 presented in the “COVID-19” section of this website.